Tag: D4t

Stavudine, an antiretroviral medication once commonly used for HIV/AIDS, is widely known by at least two other names: its brand name, Zerit, and its chemical shorthand, d4T. It was approved in the US in 1994 and became available as a generic medicine.

In 2009, the World Health Organization (WHO) recommended that countries phase out stavudine, a widely used and inexpensive antiretroviral drug, due to its severe and often irreversible long-term side effects. The decision to withdraw stavudine (d4T), marketed as Zerit, was a critical turning point in HIV treatment, prioritizing patient safety over the drug's initial accessibility.

First approved by the FDA in 1994, the antiretroviral medication Stavudine (also known as d4T) was once a key treatment for HIV. In response to the question, 'Is Stavudine still available?', the answer is no, particularly in the US and most resource-rich settings, due to severe and irreversible side effects.